004310 — Hyundai Pharmaceutical Share News
0.000.00%
- KR₩211bn
- KR₩238bn
- KR₩192bn
S.Korean stocks close little changed; won edges lower
Brief: Acerus Pharmaceuticals Announces Approval Of Natesto In South Korea
Brief: Mithra Pharmaceuticals To Commercialise Estelle In South Korea With Hyundai Pharm
Brief: Hyundai Pharmaceutical to pay annual cash dividend as 50 won/share
Brief: Hyundai Pharmaceutical to raise 13 bln won via rights issue
Brief: Hyundai Pharmaceutical to pay annual dividend as 47.5 won/share for FY 2016
Brief: Acerus announces NATESTO license agreement with Hyundai Pharm